Health
FDA Reviewing Multicancer Detection Test for Medicare Coverage
The FDA is reviewing Grail’s Galleri test, which screens for 50 cancers from a blood draw. The outcome could determine whether the test receives Medicare coverage.
Coverage timeline — 1 article
MarketWatch
Grail’s Galleri test looks for 50 cancers from a blood draw, but a major study failed to prove it could detect later-stage cancers.
2026-09-23 12:39 UTC